Linked Life Data

7444061

Source:http://linkedlifedata.com/resource/pubmed/id/7444061

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1981-2-19
pubmed:abstractText
Thirteen patients received an initial dose of 25-29.9 mCi (9259-1, 106 MB1) of 131I following partial thyroidectomy for papillary, follicular, or mixed carcinoma. Administration of thyroxine (T4) or triiodothyronine (T3) was stopped 3-12 weeks and 1-6 weeks, respectively, before therapy or imaging. Patients remained on normal diets and did not receive thyroid-stimulating hormone (TSH) or diuretics. Follow-up 3 months to 2 years after therapy demonstrated that ablation of thyroid bed activity was successful in only one patient, who still had metastases. This suggests that administration of 25-29.9 mCi of 131I following surgery is unreliable for ablation of residual thyroid bed activity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0033-8419
pubmed:author
pubmed:issnType
Print
pubmed:volume
137
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
773-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.
pubmed:publicationType
Journal Article